Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724517 | SCV000226716 | uncertain significance | not provided | 2015-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000225726 | SCV000249737 | benign | not specified | 2015-04-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002228784 | SCV001667394 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-08-14 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277351 | SCV002565681 | likely benign | Ehlers-Danlos syndrome | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408760 | SCV002723913 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-07-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |